MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma.

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma.
复制标题

miR-221 和 miR-222 靶向 PUMA 以诱导胶质母细胞瘤细胞存活。

DOI:
10.1186/1476-4598-9-229
复制
发表时间:
2010-09-02
期刊:
影响因子:
37.3
通讯作者:
Kang CS
Kang CS
中科院分区:
医学1区
文献类型:
--
作者:
Zhang CZ;Zhang JX;Zhang AL;Shi ZD;Han L;Jia ZF;Yang WD;Wang GX;Jiang T;You YP;Pu PY;Cheng JQ;Kang CS

文献摘要

参考文献

被引文献

相似文献

miR-221和miR-222(miR-221/222)在包括胶质母细胞瘤在内的各种类型的人类恶性肿瘤中频繁上调。最近的研究报道,miR-221/222通过靶向p27和p57调节细胞生长和细胞周期进程。然而,涉及miR-221/222的细胞存活调节的潜在机制仍然难以捉摸。在此,我们发现miR-221/222通过靶向人胶质瘤细胞中的促凋亡基因cDNAA来抑制细胞凋亡。miR-22/222的增强表达诱导细胞存活,而miR-221/222的敲低使细胞凋亡。此外,miR-221/222通过靶向CD 3A-3 'UTR降低CD 3A蛋白水平。引入不含3 'UTR的cDNA消除了miR-221/222诱导的细胞存活。值得注意的是,miR-221/222的敲低诱导了cDNAA表达和细胞凋亡,并显著降低了异种移植模型中的肿瘤生长。最后,在胶质瘤组织中,miR-221/222的表达与CD 45 A呈负相关。据我们所知,这些数据首次表明,miR-221/222通过靶向胶质母细胞瘤中的CRYSTA直接调节细胞凋亡,并且miR-221/222可能是胶质母细胞瘤干预的潜在治疗靶点。
MiR-221 and miR-222 (miR-221/222) are frequently up-regulated in various types of human malignancy including glioblastoma. Recent studies have reported that miR-221/222 regulate cell growth and cell cycle progression by targeting p27 and p57. However the underlying mechanism involved in cell survival modulation of miR-221/222 remains elusive. Here we showed that miR-221/222 inhibited cell apoptosis by targeting pro-apoptotic gene PUMA in human glioma cells. Enforced expression of miR-22/222 induced cell survival whereas knockdown of miR-221/222 rendered cells to apoptosis. Further, miR-221/222 reduced PUMA protein levels by targeting PUMA-3'UTR. Introducing PUMA cDNA without 3'UTR abrogated miR-221/222-induced cell survival. Notably, knockdown of miR-221/222 induces PUMA expression and cell apoptosis and considerably decreases tumor growth in xenograft model. Finally, there was an inverse relationship between PUMA and miR-221/222 expression in glioma tissues. To our knowledge, these data indicate for the first time that miR-221/222 directly regulate apoptosis by targeting PUMA in glioblastoma and that miR-221/222 could be potential therapeutic targets for glioblastoma intervention.
DOI: 10.1074/jbc.m806041200
发表时间: 2008-11-07
影响因子: 4.8
作者:
Zhao, Jian-Jun;Lin, Jianhong;Cheng, Jin Q.
通讯作者: Cheng, Jin Q.
DOI: 10.1158/0008-5472.can-05-1783
发表时间: 2005-08-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Iorio, MV;Ferracin, M;Croce, CM
通讯作者: Croce, CM
DOI: 10.1126/science.1133289
发表时间: 2007-02-09
期刊: SCIENCE
影响因子: 56.9
作者:
Willis, Simon N.;Fletcher, Jamie I.;Huang, David C. S.
通讯作者: Huang, David C. S.
DOI: 10.1016/s1097-2765(01)00213-1
发表时间: 2001-03-01
期刊: MOLECULAR CELL
影响因子: 16
作者:
Yu, J;Zhang, L;Vogelstein, B
通讯作者: Vogelstein, B
DOI: 10.1158/0008-5472.can-04-0637
发表时间: 2004-06-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Takamizawa, J;Konishi, H;Takahashi, T
通讯作者: Takahashi, T